Publications for Ingrid Jakobsen Falk
Co-author map based on ISI articles 2007-
Journal Articles
Henrik Green, Ingrid Jakobsen Falk, Kourosh Lotfi, E Paul, M Hermansson, R Rosenquist, C Paul and H Nahi
Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype
The Pharmacogenomics Journal, 2012, 12(2), 111-118.
Fulltext  Web of Science® Times Cited: 1 |
Ingrid Jakobsen Falk, Muhammad Suleman Khan, Lena Thunell, Hareth Nahi and Henrik Green
Association of CYP2B6 Genotype with Survival and Progression Free Survival in Cyclophosphamide Treated Multiple Myeloma
Journal of Cancer Therapy, 2012, 3(1), 20-27.
|
Henrik Green, Muhammad Suleman Khan, Ingrid Jakobsen Falk, Elisabeth Avall-Lundqvist and Curt Peterson
Impact of CYP3A5(*)3 and CYP2C8-HapC on Paclitaxel/Carboplatin-Induced Myelosuppression in Patients with Ovarian Cancer
Journal of Pharmaceutical Sciences, 2011, 100(10), 4205-4209.
Fulltext Web of Science® Times Cited: 2 |
Sally A Coulthard, Christopher P F Redfern, Malin Lindqvist Appell, Karin Skoglund, Ingrid Jakobsen Falk, Andrew G Hall, Gordon A Taylor and Linda A Hogarth
Increased Sensitivity to Thiopurines in Methylthioadenosine Phosphorylase-Deleted Cancers
MOLECULAR CANCER THERAPEUTICS, 2011, 10(3), 495-504.
Web of Science® Times Cited: 6 |
Conference Articles
Sally Coulthard, Christopher Redfern, Svante Vikingsson, Malin Lindqvist Appell, Karin Skoglund, Ingrid Jakobsen Falk, Andrew Hall, Gordon Taylor and Linda Hogarth
Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancers in PURINERGIC SIGNALLING, vol 6, issue , pp 33-33
PURINERGIC SIGNALLING, 2010.
|
Ph.D., Lic. Theses
